ARCH Venture Partners
96 portfolio companies · 13 on the map · $3.8B raised · 11 cities
Portfolio map
13 ARCH Venture Partners portfolio companies on the map.
Portfolio companies

Xaira Therapeutics
South San Francisco
an integrated biotechnology company driving advances in AI to transform how we treat disease.
Biotechnology Research$1BEst. 2023
Generate Biomedicines
Somerville
Generate Biomedicines is a biotech company that combines biology, machine learning, and biological engineering to create biomedicines.
Biotechnology Research$693M
eGenesis
Cambridge
EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
Biotechnology Research$456MEst. 2015
Aspen Neuroscience
La Jolla
Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.
Biotechnology Research$387MEst. 2018
Seaport Therapeutics
Boston
Seaport Therapeutics operates as a clinical stage biopharmaceutical company.
Biotechnology Research$340M
Synchron
Brooklyn
Synchron is a bioelectronics medicine company that develops neuromodulation solutions for previously-untreatable nervous system conditions.
Medical Equipment Manufacturing$330MEst. 2016
Mirador Therapeutics
San Diego
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Biotechnology Research$250MEst. 2024
Encoded Therapeutics
South San Francisco
Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.
Biotechnology Research$239.1MEst. 2014Amphora Discovery
Durham
Amphora Discovery Corporation operates as a biotechnology company.
Biotechnology Research$94.3MEst. 2001
bit.bio
Cambridge
The Cell Coding Company
Biotech$39.9MEst. 2016
Paradigm
San Francisco
Paradigm is a San Francisco-based AI-powered workspace focused on large-scale agent orchestration, backed by Y Combinator and founders from Dropbox, Intercom, Langchain, Redis, Behance, and Posthog.
AI/ML$7MEst. 2024KSQ Therapeutics
lexington
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Pharmaceutical ManufacturingSeries CEst. 2015
Quantum Circuits
Connecticut
Quantum Circuits is developing a full-stack quantum computing platform using superconducting devices with a modular, scalable architecture, aiming to build the first truly useful quantum computers. The company stems from Yale University’s q
Computer HardwareSeries BEst. 2015
More portfolio companies
81 more ARCH Venture Partners investments we track beyond the map — 96 tracked in total.
Alnylam PharmaceuticalsCambridge · Private Equity
KardiganSouth San Francisco · Series B
VizgenCambridge · Series E
ElephasMadison · Venture
Altos LabsSan Francisco · Series A
Lightcast DiscoveryCambridge · Venture
ResilienceLa Jolla · Series B
HomewardSan Francisco · Series B
Rapport TherapeuticsBoston · Series B
Pretzel TherapeuticsWaltham · Series A
Treeline BiosciencesWatertown · Series A
Tenvie TherapeuticsSouth San Francisco · Series A
LifeMine TherapeuticsCambridge · Series C
Rippl CareSeattle · Series A
Arbor BiotechnologiesCambridge · Series C
Be BiopharmaCambridge · Series C
Dewpoint TherapeuticsBoston · Series C
Magnet BiomedicineCambridge · Series A
Boundless BioLa Jolla · Series C
ArsenalBioSouth San Francisco · Series C
IlluminaSan Diego · Venture
AIRNACambridge · Series B
Chroma MedicineCambridge · Series B
Accompany HealthBethesda · Series A
HI-BioSouth San Francisco · Series B
Volastra TherapeuticsNew York · Series A
AiraLa Jolla · Series B
City TherapeuticsCambridge · Series A
Cytrellis BiosystemsBoston · Series C
Brii BiosciencesBeijing · Venture
Beam TherapeuticsCambridge · Series B
Denali TherapeuticsSan Francisco · Series B
Agios PharmaceuticalsCambridge · Series C
HiberCellNew York · Series B
AgBiomeRaleigh · Series C
Matter NeuroscienceBoulder · Seed
Genetix Biotherapeutics Inc.Somerville · Series D
Paratus SciencesNew York · Series A
Protillion BiosciencesBurlingame · Series A
Semma TherapeuticsCambridge · Series B
Fate TherapeuticsLa Jolla · Series B
Walden BiosciencesCambridge · Series A
Proof DiagnosticsCambridge · Series A
Karuna TherapeuticsBoston · Series B
AmberWaveSalem · Series E
AgrividaWoburn · Venture
ONIOxford · Series B
Happy HealthAustin · Series A
Cooledge LightingRichmond · Series A
LunaDNASan Diego · Venture
Homology MedicinesLexington · Series B
OmniomeSan Diego · Series C
Bellerophon TherapeuticsWarren · Series A
Adesto TechnologiesSanta Clara · Series D
Nanophase TechnologiesRomeoville · Venture
PRIME CoalitionCambridge · Venture
ChiasmaNeedham · Series E
Sapphire EnergySan Diego · Series C
Cambrios TechnologiesSunnyvale · Venture
MedvantxSan Diego · Series D
Classmates.comSeattle · Series B
AllozyneSeattle · Series B
MovidiusSan Mateo · Series E
Juno TherapeuticsSeattle · Series B
NextCODE HealthCambridge · Series A
Elixir PharmaceuticalsCambridge · Series D
Apropos TechnologyOak Brook · Series C
NexCuraThe Woodlands · Series C
ReceptosSan Diego · Series B
Boreal GenomicsVancouver · Series C
NuraSeattle · Series A
XteraAllen · Venture
VBI VaccinesCambridge · Series A
Appliant.comSeattle · Venture
XenoportSanta Clara · Series B
Fast TrackSan Mateo · Series D
BIND TherapeuticsCambridge · Series C
GenVecGaithersburg · Venture
MediaPhySan Jose · Series A
- NENew Era of NetworksEnglewood · Series C
Accelerator Corp.Seattle · Series C
Portfolio map
13 ARCH Venture Partners portfolio companies on the map.